TCW Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $57.7M | Sell |
1,352,384
-183,826
| -12% | -$9.98M | 0.39% | 75 |
|
|
2026
Q1 | $96.4M | Buy |
1,536,210
+106,468
| +7% | +$8.52M | 0.73% | 39 |
|
|
2025
Q4 | $136M | Buy |
1,429,742
+97,947
| +7% | +$9.6M | 0.98% | 25 |
|
|
2025
Q3 | $130M | Sell |
1,331,795
-57,903
| -4% | -$6M | 1.09% | 24 |
|
|
2025
Q2 | $149M | Buy |
1,389,698
+1,792
| +0.1% | +$181K | 1.17% | 19 |
|
|
2025
Q1 | $140M | Sell |
1,387,906
-170,647
| -11% | -$17.2M | 1.25% | 22 |
|
|
2024
Q4 | $139M | Sell |
1,558,553
-72,442
| -4% | -$6.38M | 1.17% | 22 |
|
|
2024
Q3 | $137M | Sell |
1,630,995
-147,999
| -8% | -$11.7M | 1.19% | 20 |
|
|
2024
Q2 | $137M | Buy |
1,778,994
+55,243
| +3% | +$4.04M | 1.22% | 16 |
|
|
2024
Q1 | $118M | Sell |
1,723,751
-54,227
| -3% | -$3.49M | 1.2% | 18 |
|
|
2023
Q4 | $103M | Sell |
1,777,978
-218,089
| -11% | -$11.6M | 1.15% | 23 |
|
|
2023
Q3 | $105M | Sell |
1,996,067
-195,191
| -9% | -$10.2M | 1.32% | 19 |
|
|
2023
Q2 | $119M | Buy |
2,191,258
+52,398
| +2% | +$2.74M | 1.31% | 20 |
|
|
2023
Q1 | $107M | Buy |
2,138,860
+3,713
| +0.2% | +$175K | 1.37% | 21 |
|
|
2022
Q4 | $98.8M | Sell |
2,135,147
-88,416
| -4% | -$3.83M | 1.41% | 21 |
|
|
2022
Q3 | $86.1M | Sell |
2,223,563
-38,631
| -2% | -$1.55M | 1.26% | 23 |
|
|
2022
Q2 | $84.3M | Sell |
2,262,194
-179,550
| -7% | -$7.31M | 1.1% | 24 |
|
|
2022
Q1 | $108M | Sell |
2,441,744
-113,437
| -4% | -$4.92M | 1.03% | 28 |
|
|
2021
Q4 | $109M | Sell |
2,555,181
-51,661
| -2% | -$2.17M | 0.89% | 32 |
|
|
2021
Q3 | $113K | Sell |
2,606,842
-17,406
| -0.7% | -$770K | 0.29% | 27 |
|
|
2021
Q2 | $112M | Sell |
2,624,248
-81,141
| -3% | -$3.41M | 0.97% | 26 |
|
|
2021
Q1 | $105M | Sell |
2,705,389
-616,720
| -19% | -$23.3M | 1% | 25 |
|
|
2020
Q4 | $119M | Buy |
3,322,109
+575,115
| +21% | +$20.7M | 1.04% | 27 |
|
|
2020
Q3 | $105M | Sell |
2,746,994
-52,522
| -2% | -$2.02M | 1.14% | 24 |
|
|
2020
Q2 | $98.3M | Sell |
2,799,516
-58,020
| -2% | -$2.09M | 1.15% | 24 |
|
|
2020
Q1 | $93.2M | Buy |
2,857,536
+1,006,014
| +54% | +$39.3M | 1.29% | 21 |
|
|
2019
Q4 | $83.7M | Buy |
1,851,522
+665,623
| +56% | +$27.9M | 0.93% | 34 |
|
|
2019
Q3 | $48.3M | Buy |
1,185,899
+1,164,051
| +5,328% | +$49.3M | 0.55% | 57 |
|
|
2019
Q2 | $939K | Buy |
21,848
+7,927
| +57% | +$305K | 0.01% | 249 |
|
|
2019
Q1 | $534K | Hold |
13,921
| – | – | 0.01% | 284 |
|
|
2018
Q4 | $492K | Buy |
+13,921
| New | +$505K | 0.01% | 296 |
|
|
2017
Q1 | – | Sell |
-100,485
| Closed | -$2.17M | – | 413 |
|
|
2016
Q4 | $2.17M | Sell |
100,485
-100
| -0.1% | -$2.18K | 0.02% | 338 |
|
|
2016
Q3 | $2.39M | Sell |
100,585
-8,608
| -8% | -$205K | 0.02% | 294 |
|
|
2016
Q2 | $2.55M | Buy |
109,193
+14,775
| +16% | +$320K | 0.02% | 279 |
|
|
2016
Q1 | $1.78M | Sell |
94,418
-11,005
| -10% | -$193K | 0.01% | 361 |
|
|
2015
Q4 | $1.94M | Buy |
105,423
+3,305
| +3% | +$59.2K | 0.01% | 364 |
|
|
2015
Q3 | $1.68M | Hold |
102,118
| – | – | 0.01% | 396 |
|
|
2015
Q2 | $1.81M | Sell |
102,118
-284,550
| -74% | -$5.08M | 0.01% | 414 |
|
|
2015
Q1 | $6.86M | Buy |
386,668
+15,350
| +4% | +$243K | 0.03% | 323 |
|
|
2014
Q4 | $4.92M | Sell |
371,318
-278,200
| -43% | -$3.56M | 0.02% | 404 |
|
|
2014
Q3 | $7.67M | Sell |
649,518
-13,200
| -2% | -$166K | 0.03% | 377 |
|
|
2014
Q2 | $8.46M | Buy |
662,718
+4,700
| +0.7% | +$61.1K | 0.03% | 367 |
|
|
2014
Q1 | $8.9M | Sell |
658,018
-2,694
| -0.4% | -$35.4K | 0.04% | 355 |
|
|
2013
Q4 | $7.95M | Sell |
660,712
-3,000
| -0.5% | -$35.4K | 0.03% | 380 |
|
|
2013
Q3 | $7.79M | Buy |
663,712
+1,417
| +0.2% | +$15.3K | 0.04% | 371 |
|
|
2013
Q2 | $6.14M | Buy |
+662,295
| New | +$5.62M | 0.03% | 424 |
|
Other funds holding BSX
TCW Group's BSX Position: Q2 2026 in Review
TCW Group reduced its Boston Scientific (BSX) stake by 12% in Q2 2026, selling an estimated $9.98M and leaving 1,352,384 shares worth $57.7M. The position accounts for 0.39% of the portfolio, ranked #75.
TCW Group first reported a position in BSX in Q2 2013 and has held it in 46 quarters since. The position peaked at $149M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- TCW Group held 1,352,384 shares of Boston Scientific worth $57.7M as of Q2 2026.
- TCW Group sold 183,826 Boston Scientific shares in Q2 2026, an estimated $9.98M.
- Boston Scientific made up 0.39% of TCW Group's portfolio in Q2 2026, its #75 holding.
- TCW Group first reported a position in Boston Scientific in Q2 2013 and has held it in 46 quarters since.
- TCW Group's Boston Scientific position peaked at $149M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.